Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
20 June 2014
Header
Header image
News

News

Innovative Medicines Initiative to recruit new Executive Director
18 June 2014

Mandate of current Executive Director is non-renewable and ends in December 2014  New Executive Director will be expected to manage IMI to highest standards and ensure [...] Read more

From our blog

From our blog

Three Weeks to Go until Second Innovative Medicines Initiative Launch
18 June 2014 by Magda Chlebus

Three weeks from now, the world’s largest public-private partnership in the life sciences will be getting even bigger – €1.276 billion bigger, to be exact. [...] Read more

From our blog

European Patent Office Inventor Awards for TB Research Highlights Value of Innovation
20 June 2014 by Richard Bergström

This week the European Patent Office honoured exceptional inventors, underlining their contribution to social, economic and technological progress worldwide. Among those honoured was a team [...] Read more

What we are reading

What we are reading

WEBINAR: The Patient’s Understanding of Benefit Risk
20 June 2014

The European Medicines Agency believes that incorporating the knowledge, views and preferences of patients throughout the lifecycle of medicines adds value to the scientific assessment. In addition, patient groups have been the key drivers of implementing accelerated approval pathways partnership with the FDA in the United States.

Read more

What we are reading

UK commits to new action to find breakthrough on dementia
20 June 2014

Prime Minister commits to new action to accelerate progress on dementia drugs, with a focus on patents, funding and patient access to new medicines.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail